# Equillium, Inc.: filings

EQ · Nasdaq · CIK 1746466 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eq.md) · [Financials](/companies/eq/financials.md) · [Filings](/companies/eq/filings.md) · [Insiders](/companies/eq/insiders.md)

## Reports and events: 155 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 157, 8-K 108, 10-Q 24, 3 18, 144 15, CORRESP 14, UPLOAD 12, 425 9, S-8 9, 10-K 8, DEF 14A 8, EFFECT 8, SC 13G/A 8, 424B5 7, SCHEDULE 13G 7, DEFA14A 6, S-3 5, ARS 4, PRE 14A 4, SC 13G 4, SCHEDULE 13G/A 4, 424B3 2, 4/A 2, 8-K/A 2, S-1 2, S-1/A 2, 424B4 1, 8-A12B 1, CERT 1, CT ORDER 1, DEFR14A 1, DRS 1, DRS/A 1, DRSLTR 1, RW 1, S-4 1, S-4/A 1, S-8 POS 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 17:06 ET | [8-K](/filings/0001193125-26-414364.md) | 8.01 Other events | 0001193125-26-414364 |
| 2026-08-13 | 16:15 ET | [10-Q](/filings/0001193125-26-349235.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349235 |
| 2026-08-13 | 16:10 ET | [8-K](/filings/0001193125-26-349182.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349182 |
| 2026-05-29 | 16:05 ET | [8-K](/filings/0001193125-26-248246.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-248246 |
| 2026-05-13 | 16:10 ET | [10-Q](/filings/0001193125-26-221625.md) | Quarterly report, period 2026-03-31 | 0001193125-26-221625 |
| 2026-05-13 | 16:05 ET | [8-K](/filings/0001193125-26-221595.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-221595 |
| 2026-04-15 | 09:00 ET | [DEF 14A](/filings/0001193125-26-156092.md) | Proxy statement, period 2026-05-28 | 0001193125-26-156092 |
| 2026-03-25 | 16:15 ET | [10-K](/filings/0001193125-26-124143.md) | Annual report, period 2025-12-31 | 0001193125-26-124143 |
| 2026-03-25 | 16:10 ET | [8-K](/filings/0001193125-26-124107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-124107 |
| 2026-03-13 | 08:15 ET | [8-K](/filings/0001193125-26-105083.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-105083 |
| 2025-11-13 | 16:15 ET | [10-Q](/filings/0001193125-25-280202.md) | Quarterly report, period 2025-09-30 | 0001193125-25-280202 |
| 2025-11-13 | 16:10 ET | [8-K](/filings/0001193125-25-280173.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-280173 |
| 2025-10-24 | 16:05 ET | [8-K/A](/filings/0001193125-25-249953.md) | 4.01 Change of auditor | 0001193125-25-249953 |
| 2025-10-06 | 16:05 ET | [8-K](/filings/0001193125-25-231860.md) | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-231860 |
| 2025-09-19 | 16:06 ET | [8-K](/filings/0001193125-25-209068.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-209068 |
| 2025-09-04 | 16:01 ET | [8-K](/filings/0000950170-25-113023.md) | 8.01 Other events | 0000950170-25-113023 |
| 2025-08-14 | 16:02 ET | [10-Q](/filings/0000950170-25-108834.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108834 |
| 2025-08-11 | 08:35 ET | [8-K](/filings/0001193125-25-177510.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-177510 |
| 2025-08-04 | 08:35 ET | [8-K](/filings/0001193125-25-172207.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-172207 |
| 2025-06-13 | 16:05 ET | [8-K](/filings/0000950170-25-086155.md) | 3.01 Delisting notice | 0000950170-25-086155 |
| 2025-05-22 | 17:15 ET | [8-K](/filings/0001193125-25-125153.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-125153 |
| 2025-05-14 | 16:10 ET | [10-Q](/filings/0000950170-25-071389.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071389 |
| 2025-04-24 | 09:05 ET | [8-K](/filings/0001193125-25-092435.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-092435 |
| 2025-04-10 | 07:00 ET | [DEF 14A](/filings/0000950170-25-052669.md) | Proxy statement, period 2025-05-21 | 0000950170-25-052669 |
| 2025-03-27 | 07:10 ET | [10-K](/filings/0000950170-25-045726.md) | Annual report, period 2024-12-31 | 0000950170-25-045726 |
| 2025-03-27 | 07:05 ET | [8-K](/filings/0000950170-25-045723.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-045723 |
| 2025-02-06 | 08:01 ET | [8-K](/filings/0001193125-25-021348.md) | 8.01 Other events | 0001193125-25-021348 |
| 2024-12-13 | 16:04 ET | [8-K](/filings/0001193125-24-278465.md) | 3.01 Delisting notice | 0001193125-24-278465 |
| 2024-12-12 | 16:10 ET | [8-K](/filings/0001193125-24-277043.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-277043 |
| 2024-11-13 | 16:10 ET | [10-Q](/filings/0000950170-24-126322.md) | Quarterly report, period 2024-09-30 | 0000950170-24-126322 |
| 2024-11-13 | 16:05 ET | [8-K](/filings/0000950170-24-126288.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-126288 |
| 2024-10-31 | 07:05 ET | [8-K](/filings/0001193125-24-248138.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-248138 |
| 2024-10-31 | 18:49 ET | [8-K](/filings/0001193125-24-247760.md) | 8.01 Other events | 0001193125-24-247760 |
| 2024-08-08 | 16:10 ET | [10-Q](/filings/0000950170-24-093949.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093949 |
| 2024-08-08 | 16:05 ET | [8-K](/filings/0000950170-24-093884.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093884 |
| 2024-07-23 | 16:01 ET | [8-K](/filings/0001193125-24-182856.md) | 3.01 Delisting notice | 0001193125-24-182856 |
| 2024-07-18 | 14:08 ET | [8-K](/filings/0001193125-24-180952.md) | 2.02 Results of operations | 0001193125-24-180952 |
| 2024-06-04 | 08:00 ET | [8-K](/filings/0001193125-24-153667.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-153667 |
| 2024-05-23 | 17:00 ET | [8-K](/filings/0000950170-24-064016.md) | 5.07 Shareholder vote results | 0000950170-24-064016 |
| 2024-05-09 | 16:11 ET | [10-Q](/filings/0000950170-24-056960.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056960 |
| 2024-05-09 | 16:05 ET | [8-K](/filings/0000950170-24-056890.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056890 |
| 2024-04-11 | 16:06 ET | [DEF 14A](/filings/0001193125-24-093200.md) | Proxy statement, period 2024-05-22 | 0001193125-24-093200 |
| 2024-04-01 | 08:05 ET | [8-K](/filings/0001193125-24-082709.md) | 8.01 Other events | 0001193125-24-082709 |
| 2024-03-25 | 16:11 ET | [10-K](/filings/0000950170-24-035919.md) | Annual report, period 2023-12-31 | 0000950170-24-035919 |
| 2024-03-25 | 16:05 ET | [8-K](/filings/0001193125-24-076471.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-076471 |
| 2024-03-08 | 16:01 ET | [8-K](/filings/0001193125-24-063618.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-063618 |
| 2024-02-23 | 17:12 ET | [8-K](/filings/0001193125-24-044664.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-044664 |
| 2024-02-22 | 06:08 ET | [8-K](/filings/0001193125-24-041994.md) | 8.01 Other events | 0001193125-24-041994 |
| 2023-12-21 | 08:05 ET | [8-K](/filings/0001193125-23-300417.md) | 8.01 Other events | 0001193125-23-300417 |
| 2023-11-08 | 16:10 ET | [10-Q](/filings/0000950170-23-061108.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061108 |

Page 1 of 4. [Older](/companies/eq/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 17:10 ET. No prices; not investment advice.